DB Develops First Buprenorphine Treatment Website Focused on African Americans Addicted to Opiates, their Families, and Physicians
DB’s Health and Clinical Services Division, under subcontract to JBS International, Inc., collaborated with Howard University and web developer, Barksdale Concepts, to launch Buprenorphine: Overcoming Addictions Together (www.huovercomingaddictionstogether.com), the first website that focuses on providing African Americans addicted to opiates with information about office-based buprenorphine treatment.
Part of an initiative funded by the Substance Abuse and Mental Health Services Administration, the website aims to:
Inform African Americans addicted to opiates and their families about office-based buprenorphine treatment and its benefits. Despite buprenorphine’s use for more than 10 years and its demonstrated success helping people addicted to opiates control withdrawal symptom and cravings, many African Americans are unaware of this treatment option.
Increase the number of qualified physicians in Washington, DC who offer office-based buprenorphine treatment at the 100-patient limit allowed by federal regulations. Office-based buprenorphine treatment allows patients to be treated by qualified physicians who can prescribe the medication for take-home use. However, out of the nation’s more than 700,000 physicians, only 17,000 have the necessary credentials to prescribe buprenorphine. This shortage severely limits access to treatment by those who need it.
Site visitors will find information that describes what to expect from buprenorphine treatment, addresses the science showing addiction is a chronic disease, and emphasizes the importance of combining medication with counseling and support services.
For further information, contact Randolph E. Edmead, M.S., Project Director at (301) 589-4020 extension 291 or via e-mail at firstname.lastname@example.org.